Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Shirô Nakamura's publication output changed over time?
ScholarIQpublication output · 1968–2025
Output grew0% over the shown period — from 1 works in 1968 to 1 in 2025.
1
1
2
2
1
2
1
1
19681993200220112012201820212025
What are the most-cited papers on Shirô Nakamura?
ScholarIQmost cited works
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
Hiroshi Nakase, Motoi Uchino, Shinichiro Shinzaki, Minoru Matsuura, Katsuyoshi Matsuoka, Taku Kobayashi, Masayuki Saruta, Fumihito Hirai, Keisuke Hata, Sakiko Hiraoka, Motohiro Esaki, Ken Sugimoto, Toshimitsu Fuji, Kenji Watanabe, Shirô Nakamura, Nagamu Inoue, Toshiyuki Itoh, Makoto Naganuma, Tadakazu Hisamatsu, Mamoru Watanabe, Hiroto Miwa, Nobuyuki Enomoto, Tooru Shimosegawa, Kazuhiko Koike
S41046285. 2021498 CitationsOPEN ACCESS
In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells.
Shirô Nakamura, Hitoshi Ohtani, Yasuo Watanabe, Kotaro Fukushima, Takeo MATSUMOTΟ, Atsuo Kitano, K. Kobayashi, H Nagura
PubMed. 1993201 Citations
GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis
Makoto Ooi, Shin Nishiumi, Tomoo Yoshie, Yuuki Shiomi, Michitaka Kohashi, Ken Fukunaga, Shirô Nakamura, Takayuki Matsumoto, Naoya Hatano, Masakazu Shinohara, Yasuhiro Irino, Tadaomi Takenawa, Takeshi Azuma, Masaru Yoshida
Inflammation Research. 2011178 Citations
Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease
Akira Andoh, Hiroyuki Kuzuoka, Tomoyuki Tsujikawa, Shirô Nakamura, Fumihito Hirai, Yasuo Suzuki, Toshiyuki Matsui, Yoshihide Fujiyama, Takayuki Matsumoto
S41046285. 2012164 Citations
Scheduled infliximab monotherapy to prevent recurrence of Crohnʼs disease following ileocolic or ileal resection: A 3-year prospective randomized open trial
Kōji Yoshida, Ken Fukunaga, Hiroki Ikeuchi, Koji Kamikozuru, Nobuyuki Hida, Yoshio Ohda, Yoko Yokoyama, Masaki Iimuro, Naohisa Takeda, Kyoichi Kato, Risa Kikuyama, Kazuko Nagase, Kazutoshi Hori, Shirô Nakamura, Hiroto Miwa, Takayuki Matsumoto
S45123234. 2011154 CitationsOPEN ACCESS
Related on ScholarIQ
Osaka University of Pharmaceutical Sciences
Institution
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
Paper
In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells.
Paper
GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis
Paper
Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease
Paper
Scheduled infliximab monotherapy to prevent recurrence of Crohnʼs disease following ileocolic or ileal resection: A 3-year prospective randomized open trial
Paper